Fig. 3 | Nature Communications

Fig. 3

From: Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model

Fig. 3The alternative text for this image may have been generated using AI.

Extended elimination of microglia does not induce peripheral leukocyte or behavioral abnormalities. 1.5-month-old wild-type (WT) or 5xFAD mice were treated with control chow or PLX5622 for 10 or 24 weeks. a Experimental design. b Terminal PK of PLX5622 and 5xFAD + PLX5622 groups. Two-tailed independent t-test. n = 5–6 for PLX5622, n = 8–11 for 5xFAD + PLX5622. c Hemisphere stitches of microglia (IBA1 in green) in the 7-month-old cohort. Scale bar = 1000 μm. d Analysis of different subsets of leukocytes (CD11b, p = 0.059; CD19, p = 0.052; all others NS). Two-tailed independent t-test; n = 4–5 for Wild-type, n = 3–4 for PLX5622. ef All analyses listed in respective order for retrosplenial (RS) cortex, somatosensory (SS) cortex, and thalamus. Microglial number in 4 e and 7 f month-old cohorts (4-month cohort: WT v 5xFAD, p = 0.001, NS, p < 0.001; WT v PLX5622, p < 0.001, p < 0.001, p = 0.044; 5xFAD v 5xFAD + PLX5622, p < 0.001, p < 0.001, p < 0.001. 7-month cohort: WT v 5xFAD, p = 0.015, p = 0.024, p < 0.001; WT v PLX5622, p < 0.001 for all regions; 5xFAD v 5xFAD + PLX5622, p < 0.001 for all regions). Two-way ANOVA with Tukey’s post hoc test; n = 4–6 for Wild-type, n = 4–6 for PLX5622, n = 5–8 for 5xFAD, n = 6–9 for 5xFAD + PLX5622. gh Measurements for anxiety were performed by Elevated Plus Maze (EPM) and quantified as number of arm entries (g WT v 5xFAD, NS (open) and p = 0.050 (closed); PLX5622 v 5xFAD + PLX5622, p = 0.007 (open) and p < 0.001 (closed), 5xFAD v 5xFAD + PL5622, NS (open) and p = 0.056 (closed)) and time in arms (h WT v 5xFAD, p = 0.0157 (open) and p = 0.046 (closed); PLX5622 v 5xFAD + PLX5622, p < 0.001 (open) and p < 0.001 (closed); 5xFAD v 5xFAD + PLX5622, p < 0.001 (open), p < 0.020 (closed)). i Mean latencies to a hidden platform from the Morris water maze (MWM) acquisition trials. jk Number of platform entries (j; PLX5622 v 5xFAD + PLX5622, p = 0.071) and time in platform zone (k; WT v PLX5622, p = 0.094; PLX5622 v 5xFAD + PLX5622, p = 0.073) in the MWM probe trial. For all behavioral analyses: Two-way ANOVA with Tukey’s post hoc test; n = 8–12 for Wild-type, n = 8–12 for PLX5622, n = 9–12 for 5xFAD, n = 8–9 for 5xFAD + PLX5622. Statistical significance is denoted by *p < 0.05, **p < 0.01, and ***p < 0.001. Statistical trends are denoted by #p < 0.10. NS, not significant (p > 0.10). Error bars indicate SEM

Back to article page